Optical control of pain in vivo with a photoactive mGlu(5) receptor negative allosteric modulator

Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu(5)) receptor negative allosteric modu...

Descripción completa

Detalles Bibliográficos
Autores principales: Font, Joan, López-Cano, Marc, Notartomaso, Serena, Scarselli, Pamela, Di Pietro, Paola, Bresolí-Obach, Roger, Battaglia, Giuseppe, Malhaire, Fanny, Rovira, Xavier, Catena, Juanlo, Giraldo, Jesús, Pin, Jean-Philippe, Fernández-Dueñas, Víctor, Goudet, Cyril, Nonell, Santi, Nicoletti, Ferdinando, Llebaria, Amadeu, Ciruela, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388536/
https://www.ncbi.nlm.nih.gov/pubmed/28395733
http://dx.doi.org/10.7554/eLife.23545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388536/
https://www.ncbi.nlm.nih.gov/pubmed/28395733
http://dx.doi.org/10.7554/eLife.23545

Ejemplares similares